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these regions, and on an effort to better understand the 
challenges that Indian RTTs face. Not surprisingly, 
emphasized some of the same issues, namely, the need to 
treat high patient volumes and the need for improved 
implementation and training, particularly when it comes to 
software.  “Clinical users in their areas deal with very high 
numbers of patients each day. They also deal with limited 
skilled resources to use, fast, and as safe as they can be 
made,”  
Our objective is to come up with a set of guidelines for the 
career pathways, job roles at different level and the 
curricula for each level of the concerned profession. India’s 
greatest challenge will be to accomplish this but: The RTT 
management structure is majorly managed by senior policy 
makers from the medical fraternity, and provides very 
little scope for Technical professionals to participate in 
policy decision making and to bring about any reforms. 
Aims to provide world of RTTs with a global standard in the 
holistic care and treatment of patients as they undergo the 
radiotherapy process with optimum radiotherapy planning & 
 treatment techniques to patients now and in the future. The 
accuracy with which each step is carried out can have an 
impact on both tumour control and normal tissue 
complications.  
These factors mandate a high degree of accuracy in 
treatment delivery which depends on RTTs how he 
implemented and uses the Technology  
However, the change in technology and the required 
technical skills in RT over the past 10 years have been 
extreme and have forced major reviews of the technical 
aspect of RTT. We believe that the outcome of this meeting 
will be very useful for strengthening the education and 
therefore the role of RTTs in India and across the Globe to 
develop & promote the profile of the RTT within the 
multidisciplinary team in different regions under different 
challenges and, bring the resolution to the 1. Evaluation of 
technology: Relevant endpoints from the perspective of the 
RTT, Are we geared to implement technology in India and 
Skills to implement technology Training programs in India. By 
2020 RTTs of India will be more numerous, better educated, 
healthier and more prosperous than at any time in our long 
history. 
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Postoperative adjuvant chemotherapy is firmly established 
for patients in radically resected colon cancer with stage III 
and ‘high-risk’ stage II disease. In contrast, the debate 
continues to evolve on the benefit of postoperative adjuvant 
chemotherapy for rectal cancer patients after preoperative 
(chemo)radiation and TME surgery. Neither the indivividual 
phase III trials themselves nor the meta-analyses have 
provided a secure definitive answer for the benefit of 
postoperative adjuvant chemotherapy after SCPRT or CRT. 
Hence, several different strategies have been employed to 
escalate the intensity of chemotherapy in the neoadjuvant or 
preoperative setting.  
1) Integrating additional chemotherapy/targetted agents into 
preoperative chemoradiation (CRT) schedules 
2) Integrating induction chemo (IC) prior to CRT or short 
course preoperative radiotherapy SCPRT.    
3) Integrating induction chemo (IC) alone as an alternative to 
CRT or SCPRT. 
 
4) Integrating consolidation chemo (CC) after CRT or 
SCPRT.                                                                      
5) Alternating/interpolating chemotherapy and split course 
radiotherapy (ACAR) 
6) Combinations of the above  
These strategies are explored individually and the relevant 
trials examined.  The most frequent stragey has been 
concurrent chemoradiation and Phase III studies evaluated 
low-dose oxaliplatin (50-60mg/m2) as a radiosensitizer in 
patients with resectable cancers. This strategy increased 
acute toxicity, but showd no evidence for any consistent 
improvement in short-term endpoints such as pCR or long-
term oncological outcomes. So alternative manoevres as 
above using oxaliplatin at full systemic doses are being 
explored to see if this tactic can improve DFS or OS in 
borderline/unresectable patients where the CRM is 
compromised or cancers with high risk features for 
metastatic disease such as EMVI.  
Induction chemotherapy (IC) is a potentially useful 
therapeutic approach for locally advanced operable, 
primarily unresectable or borderline resectable rectal 
cancer. IC may be a more effective  option for patients with 
rectal cancer who would require adjuvant chemotherapy 
according to clinical and histological parameters, and MRI-
based imaging. The use of neoadjuvant systemic therapy in 
operable rectal cancer has potential advantages that include 
higher rates of sphincter-sparing surgery and the possibility 
of measuring early in-vivo response to systemic treatment. 
However, neoadjuvant treatment require a close 
collaboration between surgeons, medical oncologists, 
radiation oncologists, radiologists and pathologists.  
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Preoperative radio(chemo)therapy is a preferable treatment 
because it is more effective and less toxic than postoperative 
radiochemotherapy. There are two schedules of preoperative 
radiotherapy: 5 x 5 Gy delivered over 5 days with immediate 
surgery used for resectable cancers and conventionally 
fractionated radiochemotherapy delivered over 5 weeks with 
surgery delayed for 6 weeks used for both resectable cancers 
and for cancers with threatened mesorectal fascia. There 
were several prospective and retrospective trials, systematic 
reviews and one meta-analysis that explored the issue of 
increasing the rest period between radiation and surgery. 
Stockholm III randomized trial that compared immediate with 
delayed surgery after 5 x 5 Gy showed a benefit in terms of 
lower rate of severe acute post-radiation toxicity in the 
immediate-surgery group. However, this benefit was 
counterbalanced by the increase in minor postoperative 
complications in the group with immediate surgery compared 
with that with delayed surgery. Long-term results are 
awaited. Regarding elderly patients who were unfit for 
chemotherapy, 5 x 5 Gy with delayed surgery produced 
favourable outcomes for cancers with threatened mesorectal 
fascia or for small cancers after full-thickness local excision. 
5 x 5 Gy and consolidation chemotherapy during a long 
